MedPath

STEMI Treatment Optimization by Ischemic Postconditioning and IVUS Guidance

Not Applicable
Recruiting
Conditions
ST Elevation Myocardial Infarction
Registration Number
NCT04775914
Lead Sponsor
Thomas Engstrom
Brief Summary

The purpose of is study is to investigate whether ischemic postconditioning (iPOST) and intravascular ultrasound-guided (IVUS) percutaneous coronary intervention (PCI) improve the clinical outcome of patients with ST-segment elevation myocardial infarction treated with primary PCI.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
2500
Inclusion Criteria
  • Age ≥18 years
  • Acute onset of chest pain with <12 hours duration
  • STEMI as characterized by 2 mm ST elevation in 2 or more V1 through V4 leads or presumed new left bundle branch block with minimum of 1 mm concordant ST elevation or 1 mV ST-segment elevation in the limb lead (II, III and aVF, I, aVL) and V4-V6 or ST depression in 2 or more V1 through V4 leads indicating posterior AMI.

Exclusion Criteria (iPOST2):

Pre-PCI TIMI flow 0 or 1 Potential pregnancy Inability to provide informed consent Unwillingness to consent Unavoidable to use thrombectomy Spontaneous coronary artery dissection Time from symptoms onset to PPCI > 12 hours Culprit in bypass graft Other reason for not including the patient

Exclusion Criteria (iSTEMI):

Potential pregnancy Inability to understand information in order to provide informed consent Unwillingness to consent Spontaneous coronary artery dissection Time from symptoms inset to PPCI > 12 hours Culprit in bypass graft Other reason

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Primary Outcome Measures
NameTimeMethod
iPOSTUntil expected number of events are adjudicated up til 3 years

Number of participants that experience all-cause mortality or hospitalization for heart failure

iSTEMI (IVUS)Until expected number of events are adjudicated up til 3 years

Number of participants that experience all-cause mortality, unplanned ischemia-driven revascularization and new myocardial infarction

Secondary Outcome Measures
NameTimeMethod
iPOST1 year

Quality of life

iSTEMI (IVUS)Until expected number of events are adjudicated 3 years

Definite/probable stent-thrombosis

Trial Locations

Locations (1)

Heart Center, Rigshospitalet

🇩🇰

Copenhagen, Capital Region, Denmark

Heart Center, Rigshospitalet
🇩🇰Copenhagen, Capital Region, Denmark
Thomas Engstrom, MD PhD DSci
Principal Investigator
Jacob Lønborg
Contact
+4535458176
jacob.thomsen.loenborg01@regionh.dk
Jacob T Lønborg, MD PhD DMSci
Principal Investigator
Francis Joshi, MD PhD
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.